Guardian Pharmacy Services, Inc.
Rank #39Op. LeverageGRDN · NYSE · Healthcare
Guardian Pharmacy Services, Inc. (GRDN) — Rank #39 by gross profitability (GP/assets 0.66) · ROE 19.1% · Piotroski F-Score N/A.
As-of 2026-09-15 · CIK 0001802255 · all metrics point-in-time as of the filing date.
About
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.
Show moreShow less
The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc.
was founded in 2003 and is headquartered in Atlanta, Georgia.
- Industry
- Medical Care Facilities
- Sector
- Healthcare
- State
- GA
- Filer Category
- Accelerated filer
- Fiscal Year End
- December 31
- Website
- guardianpharmacy.com
Financials
Insufficient history
Direction over 5 fiscal years
- Free cash flown/a
- Gross marginn/a
- Gross profitabilityn/a
- Net cashn/a
- Operating marginn/a
- Return on equityn/a
- Share count (dilution)n/a
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-03-11 | 2024-12-31filed 2026-03-11 |
|---|---|---|
| Income statement | ||
| Revenue | 1,448.7 | 1,228.4 |
| Revenue growth (YoY) | 17.9% | 17.9% |
| Gross profit | 292.7 | 292.7 |
| Gross margin | 20.2% | 20.2% |
| Net income | 49.2 | (110.0) |
| Net margin | 3.4% | 3.4% |
| Cash flow | ||
| Operating cash flow | 100.3 | 58.0 |
| Capital expenditures | 13.4 | — |
| Free cash flow | 86.8 | 86.8 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?